Analytical Chemistry in the Regulatory Science of Medical Devices

被引:7
|
作者
Wang, Yi [1 ]
Guan, Allan [1 ]
Wickramasekara, Samanthi [1 ]
Phillips, K. Scott [1 ]
机构
[1] US FDA, Div Biol Chem & Mat Sci, Off Sci & Engn Labs, Ctr Devices & Radiol Hlth,Off Med Prod & Tobacco, Silver Spring, MD 20993 USA
关键词
medical device; regulatory science; total product life cycle; analytical chemistry; biomaterials; FDA; CIRCULATING TUMOR-CELLS; STAPHYLOCOCCUS-AUREUS; BACTERIAL BIOFILMS; IN-SITU; DIFFERENTIAL ADHESION; RESISTANCE; HEPARIN; CONTAMINATION; CRIZOTINIB; ENRICHMENT;
D O I
10.1146/annurev-anchem-061417-125556
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
In the United States, regulatory science is the science of developing new tools, standards, and approaches to assess the safety, efficacy, quality, and performance of all Food and Drug Administration-regulated products. Good regulatory science facilitates consumer access to innovative medical devices that are safe and effective throughout the Total Product Life Cycle (TPLC). Because the need to measure things is fundamental to the regulatory science of medical devices, analytical chemistry plays an important role, contributing to medical device technology in two ways: It can be an integral part of an innovative medical device (e.g., diagnostic devices), and it can be used to support medical device development throughout the TPLC. In this review, we focus on analytical chemistry as a tool for the regulatory science of medical devices. We highlight recent progress in companion diagnostics, medical devices on chips for preclinical testing, mass spectrometry for postmarket monitoring, and detection/characterization of bacterial biofilm to prevent infections.
引用
收藏
页码:307 / 327
页数:21
相关论文
共 50 条
  • [1] Application of analytical chemistry to address regulatory challenges for medical devices
    Guo, Ji
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 254
  • [2] What is regulatory science for medical devices?
    Yamane, Takashi
    JAPANESE JOURNAL OF ARTIFICIAL ORGANS, 2019, 48 (01): : 52 - 55
  • [3] Practice of Regulatory Science (Development of Medical Devices)
    Niimi, Shingo
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2017, 137 (04): : 431 - 437
  • [4] Regulatory Science in the Review of Drugs and Medical Devices
    Koide, Akihiro
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2016, 136 (04): : 557 - 562
  • [5] Regulatory Science in Practice (Pharmaceuticals and Medical Devices Agency)
    Hojo, Taisuke
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2017, 137 (04): : 439 - 442
  • [6] Regulatory science based approach in development of novel medical devices
    Sakuma, Ichiro
    2015 37TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY (EMBC), 2015, : 1729 - 1732
  • [7] Regulatory Science on AI-based Medical Devices and Systems
    Chinzei, Kiyoyuki
    Shimizu, Akinobu
    Mori, Kensaku
    Harada, Kanako
    Takeda, Hideaki
    Hashizume, Makoto
    Ishizuka, Mayumi
    Kato, Nobumasa
    Kawamori, Ryuzo
    Kyo, Shunei
    Nagata, Kyosuke
    Yamane, Takashi
    Sakuma, Ichiro
    Ohe, Kazuhiko
    Mitsuishi, Mamoru
    ADVANCED BIOMEDICAL ENGINEERING, 2018, 7 (07) : 118 - 123
  • [8] REGULATORY SCIENCE Trust and transparency in clinical trials of medical devices
    Kramer, Daniel B.
    Cutlip, Donald E.
    NATURE REVIEWS CARDIOLOGY, 2015, 12 (09) : 503 - 504
  • [9] Analytical chemistry as science
    Ballschmiter, K
    NACHRICHTEN AUS CHEMIE TECHNIK UND LABORATORIUM, 1995, 43 : S11 - S12
  • [10] Future Vision of Regulatory Science in the Global Development of Pharmaceuticals and Medical Devices
    Nakamura, Mitsuhiro
    Ikeda, Koji
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2016, 136 (04): : 523 - 525